Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma

Cancer Medicine

Volumn 4, Issue 3, 2015, Pages 437-446

  Shigeoka, Manabu ^a   Urakawa, Naoki ^a   Nishio, Mari ^a   Takase, Nobuhisa ^a   Utsunomiya, Soken ^a   Akiyama, Hiroaki ^a   Kakeji, Yoshihiro ^a   Komori, Takahide ^a   Koma, Yu ichiro ^a   Yokozaki, Hiroshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD204; Cyr61; Esophageal cancer; Macrophage; Tumor microenvironment

Indexed keywords

ANTIGEN; CD204 ANTIGEN; COMPLEMENTARY DNA; CYSTEINE RICH PROTEIN 61; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; CYR61 PROTEIN, HUMAN; MSR1 PROTEIN, HUMAN; SCAVENGER RECEPTOR A;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CELLS BY BODY ANATOMY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKEMIA CELL LINE; LYMPH NODE METASTASIS; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MICROARRAY ANALYSIS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; THP 1 CELL; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING; CELL MOTION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CYSTEINE-RICH PROTEIN 61; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; SCAVENGER RECEPTORS, CLASS A;

EID: 84979853631     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.401     Document Type: Article

References (44)

1. Komohara, Y., M. Jinushi, and M. Takeya . 2014. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 105:1-8.
2. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica . 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549-555.
3. Heusinkveld, M., and S. H. van der Burg . 2011. Identification and manipulation of tumor associated macrophages in human cancers. J. Transl. Med. 9:216.
4. Goerdt, S., and C. E. Orfanos . 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10:137-142.
5. Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill . 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164:6166-6173.
6. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
7. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani . 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177:7303-7311.
8. Montgomery, E. A., F. T. Basman, P. Brennan, and R. Malekzadeh . 2014. Oesophageal caner. Pp. 374-382 in B. W. Stewart and C. P. Wild, eds. World Cancer Report 2014. IARC, Lyon.
9. Inoue, H. 2001. Magnification endoscopy in the esophagus and stomach. Dig. Endosc. 13:S40-S41.
10. Shigeoka, M., N. Urakawa, T. Nakamura, M. Nishio, T. Watajima, D. Kuroda, et al. 2013. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci. 104:1112-1119.
11. Nishihira, T., Y. Hashimoto, M. Katayama, S. Mori, and T. Kuroki . 1993. Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol. 119:441-449.
12. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada . 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
13. Kuang, D. M., Y. Wu, N. Chen, J. Cheng, S. M. Zhuang, and L. Zheng . 2007. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110:587-595.
14. Usami, Y., S. Satake, F. Nakayama, M. Matsumoto, K. Ohnuma, T. Komori, et al. 2008. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J. Pathol. 215:330-339.
15. Tanaka, F., A. Rizqiawan, K. Higashikawa, K. Tobiume, G. Okui, H. Shigeisi, et al. 2013. Snail promotes Cyr61 secretion to prime collective cell migration and form invasive tumor nests in squamous cell carcinoma. Cancer Lett. 329:243-252.
16. Hasita, H., Y. Komohara, H. Okabe, T. Masuda, K Ohnisi, X. F. Lei, et al. 2010. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Cancer Sci. 101:1913-1919.
17. Japan Esophageal Society. 2008. Japanese Classification of Esophageal Cancer. 10th ed. Kanehara & Co., Tokyo.
18. Sobin, L. H., M. K. Gospodarowicz, and C. Wittekind . 2011. P. 336 inTNM classification of malignant tumors, 7th ed.. Wiley-Blackwell, Hoboken, NJ.
19. Stewart, D. A., Y. Yang, L. Makowski, and M. A. Troester . 2012. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol. Cancer Res. 10:727-738.
20. Gery, S., D. Xie, D. Yin, H. Gabra, C. Miller, H. Wang, et al. 2005. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin. Cancer Res. 11:7243-7254.
21. Sun, Z. J., Y. Wang, Z. Cai, P. P. Chen, X. J. Tong, and D. Xie . 2008. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br. J. Cancer 99:1656-1667.
22. Kassis, J. N., V. M. Virador, E. A. Guancial, D. Kimm, A. S. Ho, M. Mishra, et al. 2009. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. J. Pathol. 218:495-504.
23. Xie, J. J., L. Y. Xu, Y. M. Xie, H. H. Zhang, W. J. Cai, F. Zhou, et al. 2009. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int. J. Cancer 124:2549-2558.
24. Kok, S. H., H. H. Chang, J. Y. Tsai, H. C. Hung, C. Y. Lin, C. P. Chiang, et al. 2010. Expression of Cyr61 (CCN1) in human oral squamous cell carcinoma: an independent marker for poor prognosis. Head Neck 32:1665-1673.
25. Bian, Z., Y. Peng, Z. You, Q. Wang, Q. Miao, Y. Liu, et al. 2013. CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J. Lipid Res. 54:44-54.
26. Chen, Y., and X. Y. Du . 2007. Functional properties and intracellular signaling of CCN1/Cyr61. J. Cell. Biochem. 100:1337-1345.
27. Lau, L. F. 2011. CCN1/CYR61: the very model of a modern matricellular protein. Cell. Mol. Life Sci. 68:3149-3163.
28. Emre, Y., and B. A. Imhof . 2014. Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking. Semin. Immunopathol. 36:253-259.
29. Mo, F. E., A. G. Muntean, C. C. Chen, D. B. Stolz, S. C. Watkins, and L. F. Lau . 2002. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell. Biol. 22:8709-8720.
30. Brigstock, D. R. 2003. The CCN family: a new stimulus package. J. Endocrinol. 178:169-175.
31. Rachfal, A. W., and D. R. Brigstock . 2005. Structural and functional properties of CCN proteins. Vitam. Horm. 70:69-103.
32. Bai, T., C. C. Chen, and L. F. Lau . 2010. Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J. Immunol. 184:3223-3232.
33. Xie, J. J., L. Y. Xu, Z. Y. Wu, L. Y. Li, X. E. Xu, J. Y. Wu, et al. 2011. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Eur. J. Surg. Oncol. 37:669-674.
34. Ojalvo, L. S., C. A. Whittaker, J. S. Condeelis, and J. W. Pollard . 2010. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J. Immunol. 184:702-712.
35. Zhou, Z. Q., W. H. Cao, J. J. Xie, J. Lin, Z. Y. Shen, Q. Y. Zhang, et al. 2009. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9:291.
36. Lawrence, T., and G. Natoli . 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11:750-761.
37. Pello, O. M., M. De Pizzol, M. Mirolo, L. Soucek, L. Zammataro, A. Amabile, et al. 2012. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 119:411-421.
38. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11:936-944.
39. Sica, A., and A. Mantovani . 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:787-795.
40. Fujiwara, Y., Y. Komohara, T. Ikeda, and M. Takeya . 2011. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer Sci. 102:206-211.
41. Sica, A., and V. Bronte . 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117:1155-1166.
42. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49.
43. Ohnishi, K., Y. Komohara, Y. Fujiwara, K. Takemura, X. Lei, T. Nakagawa, et al. 2011. Suppression of TLR4-mediated inflammatory response by macrophage class A scavenger receptor (CD204). Biochem. Biophys. Res. Commun. 411:516-522.
44. Neyen, C., A. Pluddemann, S. Mukhopadhyay, E. Maniati, M. Bossard, S. Gordon, et al. 2013. Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer. J. Immunol. 190:3798-3805.